← Open Payments lookup

GISELA KNEBL KOHL: Open Payments

NPI 1922217306 · WINSTON SALEM, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,057 in 113 payments from 14 companies in 2025. Trend: 2023 $1,830 · 2024 $2,191 · 2025 $2,057

Food & beverage: $2,057
CompanyPaymentsAmount
Alkermes, Inc.29$453
Otsuka America Pharmaceutical, Inc.15$296
Neurocrine BioSciences, Inc.10$242
ABBVIE INC.16$238
Teva Pharmaceuticals USA, Inc.11$135
Corium, LLC5$132
Axsome Therapeutics, Inc.6$112
Lundbeck LLC4$102
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$101
Vanda Pharmaceuticals Inc.4$89

Products named: REXULTI, ARISTADA, INGREZZA, VRAYLAR, VIVITROL, Azstarys, AUSTEDO XR, CAPLYTA.

Industry payments across NC — which companies pay providers there.